# A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder

> **NCT00888264** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 152 (estimated)

## Conditions studied

- Bipolar Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00888264
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2010-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00888264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00888264, "A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00888264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*